V draw = 2 mg 2.5 mL50 mg = 0.1 mL = 10 units Injury (2 mL water with BPC-157 anchor) Payload: GHK-Cu 2.5 mg BPC-157 0.5 mg TB-4 0.5 mg KPV 0.5 mg
Mouse models have demonstrated ipamorelin's effectiveness in reducing bone loss by promoting mineralization and preserving muscle strength, particularly in specimens exposed to corticosteroids
An insulin syringe is preferred over a standard syringe because its fine markings allow for precise, small volume measurement, which matters when a single vial is being reconstituted to a specific concentration for research use
You'll need to either increase dosing frequency to 3 per week (depleting the vial in 6.6 weeks), increase per-dose amount to 75100mcg (depleting in 57 weeks), or switch to a smaller 0.5mg vial that depletes in 5 weeks at your current protocol
Many patients choose NAD injections to support: 01 Increased energy levels 02 Improved mental clarity and focus 03 Cellular repair and recovery 04 Metabolic support 05 Healthy aging and longevity 06 Postoperative recovery support Who Is a Good Candidate for NAD Therapy
In addition to Munger, key support for this study was provided by Wilmot investigators Brad Mills, PhD, and Brian Altman, PhD.